
Europe Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030
Description
Europe Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030
The Europe Fluorescent in Situ Hybridization (FISH) market is projected to register a CAGR of 7.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Europe Fluorescent in Situ Hybridization (FISH) Market, By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others), Country (Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland, and Rest of Europe) - Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Europe Fluorescent in Situ Hybridization (FISH) market are:
• Growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine
• Increasing use of the FISH technique due to the rise in patients with breast cancer and other chronic diseases
Market Players
Some of the major market players operating in the Europe Fluorescent in Situ Hybridization (FISH) market are:
• Thermo Fisher Scientific Inc.
• Bio-Techne
• Abbott
• Agilent Technologies, Inc.
• Merck KGaA
• F. Hoffmann-La Roche Ltd
• BIOZOL Diagnostics Vertrieb GmbH
• Zytomed Systems GmbH
• Genemed Biotechnologies, Inc.
• Bio SB
• BioGenex
• BioCat GmbH
• Leica Biosystems Nussloch GmbH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
306 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market Application Coverage Grid
- 2.8 Product Lifeline Curve
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 4.3 Industry Insights
- 4.4 Conclusion
- 5 Europe Fluorescent In Situ Hybridization (Fish) Market: Regulatory Framework
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Growing Burden Of Genetic Disorders As Well As Cancer
- 6.1.2 Innovation And Advancements In Fish Products
- 6.1.3 High Funding For Research Activities
- 6.1.4 Rising Demand And Usage Of Fish Techniques
- 6.2 Restraints
- 6.2.1 High Cost Of Fish Testing
- 6.2.2 Limited Availability Of Skilled Professionals
- 6.3 Opportunities
- 6.3.1 Rising Public Awareness About The Early Detection Of Genetic Abnormalities
- 6.3.2 Rise In Development Of Specific Biomarkers And Various Probes
- 6.4 Challenges
- 6.4.1 Stringent Government Regulations For The Approval Of Fish Probes
- 6.4.2 Ethical Concerns Associated With Fish Technology
- 7 Europe Fluorescent In Situ Hybridization (Fish) Market, By Product Type
- 7.1 Overview
- 7.2 Consumables
- 7.2.1 Fish Probe
- 7.2.1.1 Fish Probe, By Probe Type
- 7.2.1.1.1 Chromosome Fish Probe
- 7.2.1.1.2 Split Fish Probes
- 7.2.1.1.3 Translocation Fish Probes
- 7.2.1.1.4 Subtelomere Fish Probes
- 7.2.1.1.5 Prenatal Fish Probes
- 7.2.1.1.6 Others Probes
- 7.2.1.2 Fish Probe, By Technology
- 7.2.1.2.1 Flow Fluorescent In Situ Hybridization
- 7.2.1.2.2 C-ish
- 7.2.1.2.3 D-ish
- 7.2.1.2.4 Q- Fluorescent In Situ Hybridization
- 7.2.1.2.5 Others
- 7.2.1.3 Fish Probe, By Type
- 7.2.1.3.1 Rna
- 7.2.1.3.1.1 Mrna
- 7.2.1.3.1.2 Mirna
- 7.2.1.3.1.3 Others
- 7.2.1.3.2 Dna
- 7.2.2 Accessory Kits & Reagents
- 7.2.2.1 Kits
- 7.2.2.2 Buffer
- 7.2.2.3 Dyes
- 7.2.2.4 Others
- 7.3 Instrument
- 7.3.1 Standalone
- 7.3.2 Portable
- 7.3.3 Handheld
- 7.4 Software
- 8 Europe Fluorescent In Situ Hybridization (Fish) Market, By Technology
- 8.1 Overview
- 8.2 Rna Fluorescent In Situ Hybridization
- 8.3 Dna Fluorescent In Situ Hybridization
- 8.4 Pna Fluorescent In Situ Hybridization
- 8.5 Others
- 9 Europe Fluorescent In Situ Hybridization (Fish) Market, By Application
- 9.1 Overview
- 9.2 Cancer Research
- 9.2.1 Cancer Research, By Cancer Type
- 9.2.1.1 Non-hematopoetic Malignancies (Solid Tumors)
- 9.2.1.1.1 Breast Cancer
- 9.2.1.1.2 Lung Cancer
- 9.2.1.1.3 Melanoma
- 9.2.1.1.4 Prostrate Cancer
- 9.2.1.1.5 Ovarian Cancer
- 9.2.1.1.6 Others
- 9.2.1.2 Hematopoetic Malignancies
- 9.2.1.2.1 Leukemia
- 9.2.1.2.2 Multiple Myeloma
- 9.2.1.2.3 Myelodysplastic Syndromes (Mds)
- 9.2.2 Cancer Research, By Product
- 9.2.2.1 Consumables
- 9.2.2.2 Instruments
- 9.2.2.3 Software
- 9.3 Genetic Research
- 9.3.1 Cytogenetics
- 9.3.2 Chromosomal Abnormalities
- 9.3.3 Others
- 9.4 Infectious Disease
- 9.4.1 Consumables
- 9.4.2 Instruments
- 9.4.3 Software
- 9.5 Personalized Medicine
- 9.6 Others
- 10 Europe Fluorescent In Situ Hybridization (Fish) Market, By Usage
- 10.1 Overview
- 10.2 Research
- 10.2.1 Instruments
- 10.2.2 Consumables
- 10.2.3 Software
- 10.3 Clinical
- 10.3.1 Consumables
- 10.3.2 Instrument
- 10.3.3 Software
- 10.4 Companion Diagnostic
- 10.4.1 Consumables
- 10.4.2 Instrument
- 10.4.3 Software
- 11 Europe Fluorescent In Situ Hybridization (Fish) Market, By End User
- 11.1 Overview
- 11.2 Diagnostic Laboratories
- 11.3 Hospitals & Clinics
- 11.4 Pharmaceuticals & Biotechnological Companies
- 11.5 Academic & Research Institutes
- 11.6 Contract Research Organizations
- 11.7 Others
- 12 Europe Fluorescent In Situ Hybridization (Fish) Market, By Distribution Channel
- 12.1 Overview
- 12.2 Retail Sales
- 12.3 Online Sales
- 12.4 Direct Tender
- 12.5 Others
- 13 Europe Fluorescent In Situ Hybridization (Fish) Market, By Region
- 13.1 Europe
- 13.1.1 Germany
- 13.1.2 U.K.
- 13.1.3 Italy
- 13.1.4 France
- 13.1.5 Spain
- 13.1.6 Russia
- 13.1.7 Switzerland
- 13.1.8 Turkey
- 13.1.9 Belgium
- 13.1.10 Netherlands
- 13.1.11 Denmark
- 13.1.12 Sweden
- 13.1.13 Poland
- 13.1.14 Norway
- 13.1.15 Finland
- 13.1.16 Rest Of Europe
- 14 Europe Fluorescent In Situ Hybridization (Fish) Market, Company Landscape
- 14.1 Company Share Analysis: Europe
- 15 Swot Analysis
- 16 Company Profile
- 16.1 Merck Kgaa
- 16.1.1 Company Snapshot
- 16.1.2 Revenue Analysis
- 16.1.3 Company Share Analysis
- 16.1.4 Product Portfolio
- 16.1.5 Recent Development
- 16.2 Abbott
- 16.2.1 Company Snapshot
- 16.2.2 Revenue Analysis
- 16.2.3 Company Share Analysis
- 16.2.4 Product Portfolio
- 16.2.5 Recent Development
- 16.3 Agilent Technologies, Inc.
- 16.3.1 Company Snapshot
- 16.3.2 Revenue Analysis
- 16.3.3 Company Share Analysis
- 16.3.4 Product Portfolio
- 16.3.5 Recent Development
- 16.4 F. Hoffmann-la Roche Ltd.
- 16.4.1 Company Snapshot
- 16.4.2 Revenue Analysis
- 16.4.3 Company Share Analysis
- 16.4.4 Product Portfolio
- 16.4.5 Recent Development
- 16.5 Thermo Fischer Scientific Inc.
- 16.5.1 Company Snapshot
- 16.5.2 Revenue Analysis
- 16.5.3 Company Share Analysis
- 16.5.4 Product Portfolio
- 16.5.5 Recent Development
- 16.6 Abcam Plc.
- 16.6.1 Company Snapshot
- 16.6.2 Revenue Analysis
- 16.6.3 Company Share Analysis
- 16.6.4 Product Portfolio
- 16.6.5 Recent Developments
- 16.7 Abnova Corporation
- 16.7.1 Company Snapshot
- 16.7.2 Product Portfolio
- 16.7.3 Recent Development
- 16.8 Bio Sb
- 16.8.1 Company Snapshot
- 16.8.2 Product Portfolio
- 16.8.3 Recent Development
- 16.9 Biocare Medical, Llc
- 16.9.1 Company Snapshot
- 16.9.2 Product Portfolio
- 16.9.3 Recent Development
- 16.10 Biocat Gmbh
- 16.10.1 Company Snapshot
- 16.10.2 Product Portfolio
- 16.10.3 Recent Development
- 16.11 Biodot
- 16.11.1 Company Snapshot
- 16.11.2 Product Portfolio
- 16.11.3 Recent Development
- 16.12 Biogenex
- 16.12.1 Company Snapshot
- 16.12.2 Product Portfolio
- 16.12.3 Recent Development
- 16.13 Bio-techne
- 16.13.1 Company Snapshot
- 16.13.2 Revenue Analysis
- 16.13.3 Company Share Analysis
- 16.13.4 Product Portfolio
- 16.13.5 Recent Development
- 16.14 Biozol Diagnostics Vertrieb Gmbh
- 16.14.1 Company Snapshot
- 16.14.2 Product Portfolio
- 16.14.3 Recent Development
- 16.15 Excilone
- 16.15.1 Company Snapshot
- 16.15.2 Product Portfolio
- 16.15.3 Recent Development
- 16.16 Genemed Biotechnologies, Inc.
- 16.16.1 Company Snapshot
- 16.16.2 Product Portfolio
- 16.16.3 Recent Development
- 16.17 Kaneka Eurogentec S.A.
- 16.17.1 Company Snapshot
- 16.17.2 Product Portfolio
- 16.17.3 Recent Development
- 16.18 Leica Biosystems Nussloch Gmbh
- 16.18.1 Company Snapshot
- 16.18.2 Product Portfolio
- 16.18.3 Recent Development
- 16.19 Metasystems
- 16.19.1 Company Snapshot
- 16.19.2 Product Portfolio
- 16.19.3 Recent Development 298
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.